Medical Weight Loss for Brookfield, Wisconsin Residents

Brookfield, Wisconsin residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Brookfield through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Same physician, wherever you live in Wisconsin: patients in Brookfield see the same Dr. Sharma and the same protocol as our Costa Mesa, California patients, just delivered by telehealth instead of in person. Results vary. Doctor review just $119 (medication separate).

Why Brookfield Residents Choose New Hope Weight Loss

Continuity is the quiet advantage Brookfield patients notice most. Because Dr. Anjmun Sharma oversees your case throughout, the person adjusting your dose in month three is the same physician who reviewed you in week one. Nothing gets lost in a handoff. That consistency, delivered by telehealth from our Costa Mesa clinic, is what turns a prescription into actual ongoing care for people all over Wisconsin.

From our Costa Mesa, California practice, we provide Brookfield with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.

We treat Brookfield patients the way we treat everyone, with one licensed physician overseeing your care and telehealth carrying that care across Wisconsin instead of asking you to drive to California. We care for patients throughout Brookfield and the western Milwaukee metro area of Waukesha County. Follow-up check-ins are handled remotely, so adjusting your dose is simple whether you live near downtown Brookfield or out toward Brookfield and the western Milwaukee metro area of Waukesha County.

Treatment is supervised by the same physician for all of Wisconsin, which means your distance from Costa Mesa changes nothing about your care or your cost. Compounded semaglutide shares its active ingredient with Wegovy and Ozempic, and for Brookfield patients it starts at $166 per month, billed separately. Wherever you live in Wisconsin, New Hope Weight Loss provides physician-supervised GLP-1 care by secure telehealth from our Costa Mesa, California clinic, with no need to travel for a visit.

GLP-1 Weight Loss Programs Available

Semaglutide 90-Day Metabolic Reset

This is the program most people ask us about first. For $499 across 90 days, or from $166/mo, you get semaglutide plus monthly physician oversight. Semaglutide uses the same active ingredient as Wegovy and Ozempic, and branded-drug trials averaged 15 to 17 percent body-weight loss. It is compounded, so it is not FDA-approved or brand-identical, and results vary.

Tirzepatide for a dual-pathway approach

From $233/mo, tirzepatide combines GLP-1 and GIP signaling. Branded-drug studies showed up to 22.5 percent loss at qualifying doses, a high-end figure that is not typical. It shares an active ingredient with Mounjaro and Zepbound.

Plan on a $119 physician review. Medication billed separately. HSA, FSA, Klarna, and Affirm accepted, and there is no extra charge for Brookfield telehealth visits.

How Telehealth Works for Brookfield

No waiting rooms, no commute across Brookfield traffic. Everything happens online. You answer a focused intake quiz about your goals and medical background, Dr. Anjmun Sharma reviews it and sees you by secure video (usually within 48 hours), and if a compounded GLP-1 is appropriate she sends the prescription to a state-licensed 503(a) pharmacy. That pharmacy ships your semaglutide or tirzepatide to your Brookfield home in cold-pack packaging that keeps it cool the whole way. Follow-up visits are by video as well, so dose adjustments and questions are handled from wherever you are in .

Frequently Asked Questions, Brookfield

Is there a New Hope Weight Loss clinic near Brookfield?

Our physical clinic is in Costa Mesa, California, and we care for patients in Brookfield, Wisconsin entirely by telehealth. You do not need a local office to start. Dr. Anjmun Sharma reviews your history and goals during a secure video consult, and your eligibility for a compounded GLP-1 program is confirmed there.

Do I have to travel to Costa Mesa from Brookfield for treatment?

No. Everything happens online, so Brookfield patients never drive to California. Your consult, follow-ups, and messaging run through a private portal. If you are approved, compounded semaglutide or tirzepatide ships straight to your Brookfield address in temperature-controlled cold-pack packaging to keep it stable in transit.

What does treatment cost for someone in Brookfield?

The physician review is $119. Compounded semaglutide starts at $166 a month, or $499 for the 90-day program, and tirzepatide starts at $233 a month. Medication is billed separately. We accept HSA, FSA, Klarna, and Affirm, and there is no distance surcharge for Brookfield patients.

What areas of Brookfield do you serve?

We serve patients from across Brookfield by telehealth, including Brookfield and the western Milwaukee metro area of Waukesha County.

Who qualifies for the program in Brookfield?

Eligibility for Brookfield patients is decided by Dr. Sharma during the medical review, based on your health history, current medications, and goals. The $119 visit is not charged if you are not a candidate, and there is no obligation to continue.

Brookfield Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Brookfield, Wisconsin by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.